Alexandria Real Estate Equities Inc  

(Public, NYSE:ARE)   Watch this stock  
Find more results for Joel Richardson�
78.48
-0.02 (-0.03%)
Jul 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 77.83 - 79.01
52 week 60.86 - 79.73
Open 79.01
Vol / Avg. 0.00/331,751.00
Mkt cap 5.59B
P/E 46.20
Div/yield 0.72/3.67
EPS 1.70
Shares 71.25M
Beta 1.09
Inst. own 108%
Oct 27, 2014
Q3 2014 Alexandria Real Estate Equities Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Sep 10, 2014
Alexandria Real Estate Equities Inc at Bank of America Merrill Lynch Global Real Estate Conference Add to calendar
Jul 29, 2014
Q2 2014 Alexandria Real Estate Equities Inc Earnings Call
Jul 28, 2014
Q2 2014 Alexandria Real Estate Equities Inc Earnings Release
Jun 25, 2014
Alexandria Real Estate Equities Inc at Mitsubishi Property REIT Conference
May 6, 2014
Q1 2014 Alexandria Real Estate Equities Inc Earnings Conference Call
May 5, 2014
Q1 2014 Alexandria Real Estate Equities Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 23.22% 21.31%
Operating margin 34.07% 32.08%
EBITD margin - 62.64%
Return on average assets 2.15% 1.83%
Return on average equity 3.72% 3.27%
Employees 215 -
CDP Score - -

Address

SUITE 299, 385 E. COLORADO BLVD
PASADENA, CA 91101
United States - Map
+1-626-5780777 (Phone)
+1-626-5780896 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT). The Company is an owner and REIT, and life science real estate company, focused on science-driven cluster development through the ownership, operation, management, selective acquisition, development, and redevelopment of properties containing life science laboratory space. The Company is a provider of real estate, technical infrastructure, and services to the life science industry. Client tenants include institutional (universities and independent non-profit institutions), pharmaceutical, biotechnology, medical device, product, and service entities and government agencies, , medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As of December 31, 2012, the Company�s operating properties were approximately 93.4% leased.

Officers and directors

Joel S. Marcus J.D., CPA. Chairman of the Board, President, Chief Executive Officer
Age: 66
Bio & Compensation  - Reuters
Dean A. Shigenaga Chief Financial Officer, Executive Vice President, Treasurer
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen A. Richardson Chief Operating Officer, Regional Market Director - San Francisco
Age: 52
Bio & Compensation  - Reuters
Thomas J. Andrews Executive Vice President, Regional Market Director � Greater Boston
Age: 52
Bio & Compensation  - Reuters
Daniel J. Ryan Executive Vice President, Regional Market Director � San Diego and Strategic Operations
Age: 47
Bio & Compensation  - Reuters
Peter M. Moglia Chief Investment Officer
Age: 46
Bio & Compensation  - Reuters
Richard B. Jennings Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
James H. Richardson Director
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John L. Atkins III Independent Director
Age: 70
Bio & Compensation  - Reuters
Maria C. Freire Ph.D. Independent Director
Age: 60
Bio & Compensation  - Reuters